Antibody drug conjugates and methods

Details for Australian Patent Application No. 2005249490 (hide)

Owner Genentech, Inc.

Inventors Ebens, Jr. Allen J.; Sliwkowski, Mark X.; Polakis, Paul; Jacobson, Frederic S.; Spencer, Susan D.; Schwall, Ralph H.

Agent Griffith Hack

Pub. Number AU-B-2005249490

PCT Pub. Number WO2005/117986

Priority 60/616,098 05.10.04 US; 60/576,517 01.06.04 US

Filing date 31 May 2005

Wipo publication date 15 December 2005

Acceptance publication date 29 July 2010

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

7 December 2006 PCT application entered the National Phase

  PCT publication WO2005/117986 Priority application(s): WO2005/117986

29 July 2010 Application Accepted

  Published as AU-B-2005249490

25 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005249492-Methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by cancer patients

2005249488-Packaged flavor enhanced fruits or vegetables products with extended shelflife for mass market distribution and consumption